Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
Australian biopharma company developing therapeutic cannabinoid products and psychedelic medicines Incannex Healthcare (NASDAQ:
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What’s Going On?
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday.
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood’s Latest Moves And More
Psychedelics Take Center Stage In Davos
Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
Life sciences biotech company Cybin Inc. (NYSE: CYBN) announced its selection of the Generalized Anxiety Disorder (GAD) with or without Major Depressive Disorder (MDD) as the target indication for its proprietary deuterated DMT molecule, CYB004.
Minecraft Poet Releases Art Into Public Domain After Mind-Bending Psychedelics Experience: ‘I’d Rather Give My Art Away Than Sell It’
This article by Joana Scopel was originally published in El Planteo and appears here with permission.
Psychedelics Company Revive Raises $3.2M To Target Infectious Diseases, Disorders
Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) raised funds to treat infectious diseases and rare disorders, including meth addiction.<
Cathie Wood Reacts To Atai’s Drastic Stock Plunge After Doomed Clinical Study Results
After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche
In Canada And In Jamaica You Can Produce Psychedelics — With Contrasting Legal Differences
Red Light Holland Moves Full Speed Towards Canadian Controlled Drugs and Substances Dealer's License
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space.